EssilorLuxottica (OTCMKTS:ESLOY) Shares Gap Down – Here’s What Happened

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) shares gapped down prior to trading on Wednesday . The stock had previously closed at $143.39, but opened at $137.81. EssilorLuxottica shares last traded at $138.67, with a volume of 115,067 shares changing hands.

Analysts Set New Price Targets

ESLOY has been the topic of several research analyst reports. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of EssilorLuxottica in a research note on Tuesday, October 28th. HSBC raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Wednesday, January 14th. Zacks Research downgraded shares of EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Kepler Capital Markets raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Thursday, January 15th. Finally, The Goldman Sachs Group reiterated a “buy” rating on shares of EssilorLuxottica in a research note on Friday, December 5th. Two analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, EssilorLuxottica presently has a consensus rating of “Buy”.

EssilorLuxottica Stock Performance

The stock’s 50-day moving average price is $157.88 and its 200-day moving average price is $163.57. The company has a debt-to-equity ratio of 0.18, a current ratio of 0.97 and a quick ratio of 0.67.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.